GM Advisory Group LLC Reduces Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

GM Advisory Group LLC cut its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.1% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 9,069 shares of the healthcare conglomerate’s stock after selling 293 shares during the period. GM Advisory Group LLC’s holdings in UnitedHealth Group were worth $5,303,000 as of its most recent SEC filing.

Other hedge funds have also recently bought and sold shares of the company. Allen Capital Group LLC lifted its position in shares of UnitedHealth Group by 2.9% during the third quarter. Allen Capital Group LLC now owns 10,337 shares of the healthcare conglomerate’s stock worth $6,044,000 after purchasing an additional 291 shares during the last quarter. Biltmore Family Office LLC lifted its position in shares of UnitedHealth Group by 32.0% in the 3rd quarter. Biltmore Family Office LLC now owns 735 shares of the healthcare conglomerate’s stock worth $430,000 after buying an additional 178 shares during the last quarter. CFS Investment Advisory Services LLC increased its position in UnitedHealth Group by 12.1% in the third quarter. CFS Investment Advisory Services LLC now owns 2,517 shares of the healthcare conglomerate’s stock worth $1,472,000 after buying an additional 272 shares during the period. Raymond James Trust N.A. boosted its holdings in shares of UnitedHealth Group by 3.5% during the third quarter. Raymond James Trust N.A. now owns 72,401 shares of the healthcare conglomerate’s stock valued at $42,331,000 after acquiring an additional 2,475 shares during the period. Finally, AlphaCore Capital LLC lifted its position in UnitedHealth Group by 28.7% in the 3rd quarter. AlphaCore Capital LLC now owns 606 shares of the healthcare conglomerate’s stock valued at $354,000 after purchasing an additional 135 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages have commented on UNH. Barclays dropped their price target on shares of UnitedHealth Group from $604.00 to $603.00 and set an “overweight” rating on the stock in a research note on Tuesday, October 22nd. Morgan Stanley cut their target price on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a research note on Wednesday, October 16th. KeyCorp assumed coverage on shares of UnitedHealth Group in a research note on Friday, October 11th. They set an “overweight” rating and a $675.00 price objective on the stock. Truist Financial reaffirmed a “buy” rating and issued a $625.00 price target (down from $640.00) on shares of UnitedHealth Group in a research note on Wednesday, October 16th. Finally, Royal Bank of Canada lowered their price target on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 16th. Four analysts have rated the stock with a hold rating, seventeen have given a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $615.53.

UnitedHealth Group Price Performance

UnitedHealth Group stock opened at $597.56 on Friday. The company has a market capitalization of $549.92 billion, a PE ratio of 38.93, a price-to-earnings-growth ratio of 1.69 and a beta of 0.58. The business has a 50 day simple moving average of $582.70 and a 200 day simple moving average of $551.92. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, topping the consensus estimate of $7.00 by $0.15. The firm had revenue of $100.82 billion for the quarter, compared to analysts’ expectations of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The company’s quarterly revenue was up 9.2% compared to the same quarter last year. During the same period in the prior year, the firm earned $6.56 earnings per share. On average, sell-side analysts forecast that UnitedHealth Group Incorporated will post 27.6 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be given a dividend of $2.10 per share. The ex-dividend date is Monday, December 9th. This represents a $8.40 annualized dividend and a yield of 1.41%. UnitedHealth Group’s dividend payout ratio (DPR) is 54.72%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.